OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

OTEZLA 30 MG Israel - English - Ministry of Health

otezla 30 mg

amgen europe b.v. - apremilast - film coated tablets - apremilast 30 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

APREMIL 30 MG Israel - English - Ministry of Health

apremil 30 mg

mapi pharma ltd, israel - apremilast - tablets - apremilast 30 mg - apremilast - for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

Otezla 30mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

otezla 30mg tablets

celgene ltd - apremilast - tablet - 30mg

OTEZLA TABLET 30 MG Singapore - English - HSA (Health Sciences Authority)

otezla tablet 30 mg

amgen biotechnology singapore pte ltd - apremilast - tablet, film coated - apremilast 30 mg

Supota 30 mg film-coated tablets Malta - English - Medicines Authority

supota 30 mg film-coated tablets

adalvo limited malta life sciences park, building 1, level 4 sir temi zammit san gwann industrial est, sgn 3000 san gwann, malta - film-coated tablet - apremilast 30 mg - immunosuppressants